市场调查报告书
商品编码
1361125
切向流过滤市场规模- 按产品类型(系统{一次性、可重复使用}、膜、配件)、技术(微滤)、应用(蛋白质纯化)、最终用途(製药和生物技术公司)、全球预测,2023 年 - 2032Tangential Flow Filtration Market Size - By Product Type (Systems {Single-use, Reusable}, Membrane, Accessories), Technology (Microfiltration), Application (Protein Purification), End-use (Pharma & Biotech Companies), Global Forecast, 2023 - 2032 |
2023 年至 2032 年间,全球切向流过滤市场的复合年增长率将达到 11.8%。生物製药行业不断扩大的足迹需要高效且可扩展的纯化方法,而 TFF 可以提供高生产率和产量。对精准医疗和生物技术应用的日益关注推动了生物分子分离和浓缩领域对 TFF 的需求。此外,出于环境考虑,TFF 在水处理和食品加工中被采用。总体而言,切向流过滤市场的成长是由其多功能性、成本效益以及在关键产业中的关键角色所推动的。
领先企业的不断扩张的行业扩张支持了市场成长。例如,2023 年 9 月,专门从事下游应用的着名生物加工技术公司 Verdot 推出了 FlexiPro TFF。这种符合 GMP 的多用途切向流过滤 (TFF) 系统满足了市场对基因治疗、疫苗和基于 mRNA 的治疗产品日益增长的需求。该系统的开发借鉴了 Verdot 广泛的研发专业知识,这些专业知识源自于其先前在设计、製造和测试客製化不銹钢 TFF 撬装装置方面的工作。
整个切向流过滤市场根据产品类型、最终用途和地区进行分类。
薄膜过滤器领域将在 2023 年至 2032 年间经历重大发展。薄膜过滤器在 TFF 系统中发挥关键作用,促进生物分子的分离和浓缩。这项需求是由生物製药、生物技术和环境领域不断扩大的应用所推动的。随着薄膜过滤器正在成为确保高效、精确的生物分子处理的关键因素,它们对切向流过滤市场规模的贡献不断增长。
合约研究组织和合约製造组织部门从 2023 年到 2032 年将实现令人称讚的复合年增长率。这些实体需要高效且通用的纯化方法来进行生物製药生产和研究。 TFF 精确分离和浓缩生物分子的能力使其在这些领域不可或缺,符合他们对高品质、可扩展製程的需求。这种不断增长的需求证明了 TFF 在支持生物製药行业不断扩大的外包需求方面的重要性。
欧洲切向流过滤市场从 2023 年到 2032 年将呈现可观的复合年增长率。这一增长归因于该地区强劲的生物製药行业以及对生物技术研究和生产的日益重视。
例如,2023 年9 月,根据伦敦大学研究人员的见解,用于细胞转染以诱导基因表现的慢病毒载体(LV) 表现出卓越的能力,能够承受两倍于正常值的剪切速率,同时保持同等的生产力水准。在评估渗滤期间的剪切力时,科学家采用了切向流过滤 (TFF) 的超缩小 (USD) 模拟。 TFF 提高流程效率和产品品质的能力使其成为这些领域的重要组成部分。随着欧洲仍处于创新生物製药和生物技术发展的前沿,其采用率持续成长。
Global Tangential Flow Filtration Market will witness 11.8% CAGR between 2023 and 2032. The biopharmaceutical industry's expanding footprint demands efficient and scalable purification methods, with TFF offering high productivity and yield. The increasing focus on precision medicine and biotechnology applications fuels the demand for TFF in the separation and concentration of biomolecules. Additionally, environmental concerns have led to the adoption of TFF in water treatment and food processing. Overall, the tangential flow filtration market growth is driven by its versatility, cost-effectiveness, and crucial role in critical industries.
The rising industry expansion by leading companies supports market growth. For instance, in September 2023, Verdot, a prominent bioprocessing technology firm specializing in downstream applications, introduced the FlexiPro TFF. This GMP-compliant, multipurpose tangential flow filtration (TFF) system responds to the increasing market need for gene therapy, vaccines, and mRNA-based therapeutic products. The development of this system draws from Verdot's extensive research and development expertise, derived from its prior work in designing, manufacturing, and testing custom stainless-steel TFF skid units.
The overall Tangential Flow Filtration Market is classified based on product type, end-use, and region.
The membrane filter segment will undergo significant development from 2023 to 2032. Membrane filters play a pivotal role in TFF systems, facilitating the separation and concentration of biomolecules. This demand is driven by the expanding applications in biopharmaceuticals, biotechnology, and environmental sectors. As membrane filters are becoming a critical factor in ensuring efficient and precise biomolecule processing, their contribution to the tangential flow filtration market size continues to grow.
The contract research organizations and contract manufacturing organizations segment will register a commendable CAGR from 2023 to 2032. These entities require efficient and versatile purification methods for biopharmaceutical production and research. TFF's ability to separate and concentrate biomolecules with precision has made it indispensable in these sectors, aligning with their need for high-quality, scalable processes. This growing demand supports the TFF's significance in supporting the biopharmaceutical industry's expanding outsourcing requirements.
Europe tangential flow filtration market will showcase an appreciable CAGR from 2023 to 2032. This uptick is attributed to the region's robust biopharmaceutical industry and the increasing emphasis on biotechnology research and production.
For instance, in September 2023, according to insight from researchers at the University of London, Lentiviral vectors (LVs), employed for cell transfection to induce gene expression, exhibit a remarkable ability to endure shear rates that are twice the norm while sustaining equivalent productivity levels. In assessing shear forces during diafiltration, scientists employed an ultra-scale-down (USD) mimic of tangential flow filtration (TFF). TFF's ability to enhance process efficiency and product quality has made it a vital component in these sectors. Its adoption continues to grow as Europe remains at the forefront of innovative biopharmaceutical and biotechnology developments.